Target intelligence / Profile preview

Ribosomal protein L30 pseudogene 2 (RPL30P2)

Target
RPL30P2
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein L30 pseudogene 2 (RPL30P2) is a processed pseudogene in the human genome. Pseudogenes like RPL30P2 are remnants of gene duplication or retrotransposition events and do not encode functional proteins. In this case, RPL30P2 is related to the functional RPL30 gene, which encodes a component of the large 60S ribosomal subunit, but RPL30P2 itself is non-functional, lacking introns and often containing frame disruptions or lacking regulatory elements necessary for expression[1][4][6]. There are many ribosomal protein pseudogenes in the human genome due to the high level of gene duplication in ribosomal protein families[4]. These pseudogenes do not play a direct biological role, are not therapeutic targets, and are not associated with disease as primary causes or biomarkers[4][5][6]. Key Points: - RPL30P2 is not a functional protein or receptor; it is a processed pseudogene. - It does not participate in biological pathways targeted by drugs. - It should not be considered a therapeutic target, and its primary significance is as a genomic relic of ribosomal protein gene duplication events. If structured information is needed for the related functional gene, refer to RPL30 (Ribosomal protein L30), which is a genuine ribosomal protein gene involved in protein synthesis, but not RPL30P2[3][5].

Other names
RP L30 pseudogene 2RPL30P2

Beyond the preview

Go deeper on Ribosomal protein L30 pseudogene 2 (RPL30P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L30 pseudogene 2 (RPL30P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call